Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators. Bakris GL, et al. Among authors: mcgill jb. Hypertension. 2005 Dec;46(6):1309-15. doi: 10.1161/01.HYP.0000190585.54734.48. Epub 2005 Nov 14. Hypertension. 2005. PMID: 16286578
Anemia and the role of erythropoietin in diabetes.
McGill JB, Bell DS. McGill JB, et al. J Diabetes Complications. 2006 Jul-Aug;20(4):262-72. doi: 10.1016/j.jdiacomp.2005.08.001. J Diabetes Complications. 2006. PMID: 16798479 Review.
Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators. Messerli FH, et al. Among authors: mcgill jb. Am J Med. 2007 Jul;120(7):610-5. doi: 10.1016/j.amjmed.2006.10.017. Am J Med. 2007. PMID: 17602935 Clinical Trial.
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M. Wright JT Jr, et al. Among authors: mcgill jb. J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9. doi: 10.1111/j.1524-6175.2007.07251.x. J Clin Hypertens (Greenwich). 2007. PMID: 17978591 Free PMC article. Clinical Trial.
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
Rosenstock J, Bergenstal R, Defronzo RA, Hirsch IB, Klonoff D, Boss AH, Kramer D, Petrucci R, Yu W, Levy B; 0008 Study Group. Rosenstock J, et al. Diabetes Care. 2008 Nov;31(11):2177-82. doi: 10.2337/dc08-0315. Epub 2008 Aug 4. Diabetes Care. 2008. PMID: 18678610 Free PMC article. Clinical Trial.
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators. Phillips RA, et al. Among authors: mcgill jb. J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x. J Cardiometab Syndr. 2008. PMID: 19040589 Clinical Trial.
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M. Rosenstock J, et al. Among authors: mcgill jb. Diabetologia. 2009 Sep;52(9):1778-88. doi: 10.1007/s00125-009-1415-7. Epub 2009 Jun 13. Diabetologia. 2009. PMID: 19526210 Free PMC article. Clinical Trial.
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M. Rosenstock J, et al. Among authors: mcgill jb. Diabetologia. 2009 Sep;52(9):1971-3. doi: 10.1007/s00125-009-1452-2. Epub 2009 Jul 16. Diabetologia. 2009. PMID: 19609501 Free PMC article. Clinical Trial. No abstract available.
251 results